InMed Pharmaceuticals Inc.

INM

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001728328

SEC filings (opens in a new tab)

In the last 90 days, InMed Pharmaceuticals Inc. insiders filed 7 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $4.18M in total; no superinvestor holds it.

Other share classesMTRI

Key figures

Market capClose on Nov 6, 2026: $8.55M
Insider buysLast 90 days, $238.4K in total: 7
Insider sellsOpen market, last 90 days: 0
13F holdersQ2 2026, +11 vs. previous quarter: 20
13F valueReported value at the end of Q2 2026: $4.18M
Superinvestors holdingAt the end of Q2 2026: 0

Price chart

Chart by TradingView (opens in a new tab)

Financials

See financial statements

From SEC filings, in USD.

Revenue, FY2026: –; No comparable prior period
Net income, FY2026: -$12.6M; No comparable prior period
Free cash flow, FY2026: –; No comparable prior period
Revenue, Q1 FY2027: –; No comparable prior period

Short interest

See short data

From FINRA, settlement date Oct 30, 2026.

Short interest: 63.4K; Shares sold short
Change: +56.8K; +855.8% vs. previous
Days to cover: 1.00; At average daily volume

Superinvestors holding INM, Q2 2026

Go to the superinvestors tab

No superinvestor reported holding INM at the end of Q2 2026.

Latest insider trades

See all insider trades

Open-market purchases and sales by InMed Pharmaceuticals Inc. insiders from Form 4, newest first.

Insider trades
Filed (ET)	Trade date	Filing delay	Insider	Transaction	Shares	Avg price	Value	Holding change	Flags
Nov 9, 2026 (view filing)8:18 PM ET	Nov 5	4 days	Schneeberger Daniel and 1 other10% Owner	PPurchase	+2.64K	$13.10	+$34.6K	+2.8%98.3K after
Oct 27, 2026 (view filing)2:13 PM ET	Oct 23	4 days	Schneeberger Daniel and 1 other10% Owner	PPurchase	+4	$1.32	+$5.28	0.0%956.6K after
Oct 20, 2026 (view filing)5:31 PM ET	Oct 16-19	4 days	Schneeberger Daniel and 1 other10% Owner	PPurchase	+1.09K	$1.32	+$1.43K	+0.1%956.6K after	2 lots
Oct 15, 2026 (view filing)4:39 PM ET	Oct 13-15	2 days	Schneeberger Daniel and 1 other10% Owner	PPurchase	+9.57K	$1.33	+$12.7K	+1.0%955.5K after	3 lots
Oct 8, 2026 (view filing)6:27 PM ET	Oct 6-8	2 days	Schneeberger Daniel and 1 other10% Owner	PPurchase	+10.9K	$1.33	+$14.5K	+1.2%945.9K after	3 lots
Oct 5, 2026 (view filing)5:11 PM ET	Oct 1-5	4 days	Schneeberger Daniel and 1 other10% Owner	PPurchase	+42.9K	$1.33	+$57.1K	+4.8%935.0K after	3 lots
Sep 16, 2026 (view filing)6:58 PM ET	Sep 14-16	2 days	Schneeberger Daniel and 1 other10% Owner	PPurchase	+91.1K	$1.30	+$118.1K	+11.4%892.1K after	3 lots
Jul 17, 2026 (view filing)7:29 PM ET	Jul 15	2 days	Schneeberger Daniel and 1 other10% Owner	PPurchase	+1.00K	$1.56	+$1.55K	+0.1%801.0K after
Jul 16, 2026 (view filing)9:58 PM ET	Jul 14-16	2 days	Vivo Opportunity, LLC and 3 others10% Owner	PPurchase	+20.5K	$1.55	+$31.8K	+37.7%75.0K after	6 lots
Jul 2, 2026 (view filing)7:02 PM ET	Jun 30-Jul 2	2 days	Vivo Opportunity, LLC and 3 others10% Owner	PPurchase	+6.55K	$1.55	+$10.1K	+9.8%73.1K after	6 lots

Top 10 13F holders, Q2 2026

See all 20 holders

The largest institutional positions in InMed Pharmaceuticals Inc. at the end of Q2 2026; share changes are against Q1 2026.

Institutions holding INM in Q2 2026
Institution	Shares	Value	% of portfolio	Change in shares	Action
ADAR1 Capital Management, LLC	800,000	$1.24M	0.06%	+800,000	New
Vivo Capital, LLC	798,377	$1.24M	0.11%	+798,377	New
Squadron Capital Management LLC	325,000	$503.8K	0.17%	+325,000	New
Ikarian Capital, LLC	245,025	$379.8K	0.06%	+245,025	New
Ursa Fund Management, LLC	125,800	$195.0K	0.03%	+125,800	New
Suvretta Capital Management, LLC	100,000	$155.0K	0.00%	+100,000	New
Boothbay Fund Management, LLC	74,244	$115.1K	0.00%	+74,244	New
Sabby Management, LLC	44,970	$69.7K	0.58%	−175,290−79.6%	Reduced
Jane Street Group, LLC	43,078	$66.8K	0.00%	+43,078	New
VR Adviser, LLC	32,685	$50.7K	0.00%	+32,685	New

Holders of 5% or more of INM

See all 5 holders and filings

Holders whose latest Schedule 13D or 13G filing reports 5% or more of InMed Pharmaceuticals Inc..

Largest holders of INM from 13D and 13G filings
Holder	Latest form	Stake	Change	First filed	Latest filing	Filing
Vivo Opportunity Fund Holdings, L.P.	13D	21.70%718.4K shares	New	Jun 10, 20261 filing	Jun 10, 2026	SEC
ADAR1 Capital Management, LLC	13G/A	17.20%943.7K shares	−6.90 ppfrom 24.10%	Jun 5, 20262 filings	Oct 7, 2026	SEC
YA II PN, Ltd.	13G	9.99%80.4K shares	New	Dec 18, 20241 filing	Dec 18, 2024	SEC
Sabby Management, LLC	13G	9.90%280.1K shares	New	Jan 20, 20261 filing	Jan 20, 2026	SEC
Squadron Capital Management LLC	13G	9.80%325.0K shares	New	May 27, 20261 filing	May 27, 2026	SEC